Chandra Bhagat Pharma IPO vs Tranway Technologies IPO

Comparison between Chandra Bhagat Pharma IPO and Tranway Technologies IPO.

IPO Details

Chandra Bhagat Pharma IPO is a SME Fixed Price IPO proposed to list at BSE SME while Tranway Technologies IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Chandra Bhagat Pharma IPO is up to ₹9.69 Cr whereas the issue size of the Tranway Technologies IPO is up to ₹4.02 Cr. The final issue price of Chandra Bhagat Pharma IPO is ₹51.00 per share and of Tranway Technologies IPO is ₹10.00 per share.

 Chandra Bhagat Pharma IPOTranway Technologies IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹51.00 per share₹10.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size2000 shares10000 shares
Fresh Issue Size19,00,000 shares40,20,000 shares
Fresh Issue Size (Amount)up to ₹9.69 Crup to ₹4.02 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total19,00,000 shares40,20,000 shares
Issue Size Total (Amount)up to ₹9.69 Crup to ₹4.02 Cr

IPO Timetable

Chandra Bhagat Pharma IPO opens on Jan 31, 2020, while Tranway Technologies IPO opens on Jan 27, 2020. The closing date of Chandra Bhagat Pharma IPO and Tranway Technologies IPO is Feb 06, 2020, and Jan 29, 2020, respectively.

 Chandra Bhagat Pharma IPOTranway Technologies IPO
Issue OpenJan 31, 2020Jan 27, 2020
Issue CloseFeb 06, 2020Jan 29, 2020
Basis Of Allotment (Tentative)Feb 11, 2020Feb 03, 2020
Initiation of Refunds (Tentative)Feb 13, 2020Feb 04, 2020
Credit of Share (Tentative)Feb 13, 2020Feb 05, 2020
Listing date (Tentative)Feb 14, 2020Feb 05, 2020

Financials & KPIs

Chandra Bhagat Pharma IPO P/E ratio is 51, as compared to Tranway Technologies IPO P/E ratio of 90.

 Chandra Bhagat Pharma IPOTranway Technologies IPO
Financials

Company Financials (Restated)

Period Ended31 Jul 201931 Mar 201931 Mar 201831 Mar 2017
Assets85.9482.8658.0655.90
Total Income33.45106.7297.7390.28
Profit After Tax0.250.631.030.66
EBITDA1.474.674.754.39
NET Worth13.5313.288.017.41
Reserves and Surplus9.2613.708.036.99
Total Borrowing15.0117.6317.2210.62
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended30 Sep 201931 Mar 201931 Mar 201831 Mar 2017
Assets2.712.142.421.08
Total Income2.295.183.943.12
Profit After Tax0.060.240.110.12
NET Worth0.620.550.310.20
Reserves and Surplus0.600.530.290.18
Total Borrowing1.721.331.550.57
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)95.82%99.98%
Promoter Shareholding (Post-Issue)70.42%59.99%
P/E Ratio5190
Market Cap₹38.48 Cr.₹10.60 Cr.

Shares Offered

In the Chandra Bhagat Pharma IPO Retail Individual Investors (RII) are offered 9,50,000 shares while in Tranway Technologies IPO retail investors are offered 9,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Chandra Bhagat Pharma IPO and in Tranway Technologies IPO.

 Chandra Bhagat Pharma IPOTranway Technologies IPO
Market Maker Reservation1,00,000 shares2,20,000 shares
NII9,50,000 shares20,10,000 shares
RII9,50,000 shares20,10,000 shares
Total19,00,000 shares40,20,000 shares

Bids Received (Subscription)

Chandra Bhagat Pharma IPO subscribed 1.65x in total, whereas Tranway Technologies IPO subscribed 1.98x.

Compare with others

Compare:

Chandra Bhagat Pharma IPO Vs Tranway Technologies IPO